Colorectal Cancer: Managing Recurrent Disease

Video

Colorectal Cancer: Managing Recurrent Disease

January 2017

A 62-year-old African-American man presented with recurrent CRC

  • Diagnosed at age 55 with stage 3 CRC, treated with surgery and adjuvant FOLFOX
  • He underwent colonoscopy with biopsy
    • 6-cm ulcerated non-obstructive mass noted in the right colon
    • Pathology confirmed poorly-differentiated adenocarcinoma
    • Staging; T3N1M0
  • History
    • Former smoker, 1 pack a day; quit 20 years ago
    • Obese, BMI = 30.2 kg/m2
    • Mother had inflammatory bowel disease, died at age 70
    • Other medications: metoprolol for hypertension, omeprazole, regular NSAID use
  • PET/CT scan showed recurrent disease with multiple metastases in liver
    • CEA, 28.4 ng/mL
    • Biopsy of liver lesions suggests poorly-differentiated with colon primary
    • Mutation analysis;KRASandNRAS,WT;BRAF-wild-type; microsatellite-stable
  • He was started on FOLFIRI with bevacizumab and achieved partial response

January 2018

  • The patient reports feeling short of breath.
  • PET/CT showed progressive disease in the liver and multiple metastases in both lung fields
  • Therapy options were discussed with the patient; he preferred an oral therapy
  • He was started on regorafenib, 80 mg once daily
    • He experienced grade 2 dermatologic toxicity on his hands and feet (palmar-plantar erythrodysesthesia syndrome [PPES]), which was managed with dose escalation from 80 mg to 120 mg to 160 mg. With recovery, he resumed regorafenib at 120 mg/day
    • At present,he remains on regorafenib 120 mg/day with evidence of stable disease at 6-month follow-up
Related Videos
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Stephen T. Oh, MD, PhD, an expert on myelofibrosis
Related Content